>>18748871 lb
>Donald Trump floats that Tucker Carlson left Fox because he wanted 'free rein'
Hostage no more?
>'free rein'
Free Rain
April Showers
1257
Apr 24,2018 11:42:14 AM EDT
Q !xowAT4Z3VQ ID: bc4b43 No. 1169294
Apr 24, 2018 11:37:59 AM EDT
Q !xowAT4Z3VQ ID: bc4b43 No. 1169241
Apr 24, 2018 11:30:18 AM EDT
Q !xowAT4Z3VQ ID: bc4b43 No. 1169138
>>1169112
His sole purpose [WH visit] is to convince POTUS, on behalf of the EU, to remain in the Iran deal.
You decide.
Q
>>1169138
Whatâs at risk?
$250B x 2 / year.
What the taxpayers donât know.
Why arenât NK developments receiving WW praise?
We endure.
Q
>>1169241
HOSTAGE NO MORE.
Q
1146
Apr 14, 2018 2:24:45PM EDT
Q !xowAT4Z3VQ ID: 072bee No. 1041555
901FFF2C-CFFC-4586-8226-7âŚ.jpeg
Expand your thinking.
The âdateâ vs âactualâ.
Iran next.
Trust the plan!
APRIL SHOWERS.
[SHOWERS].
Do you believe in coincidences?
Q
>Hunter Biden hides away at Joe Kianiâs
>$50M California vineyard amid his brewing
>criminal probes:
Joe Kiani
Iranian
Covid Med tech Billionaire
'Meet The Iranian Immigrant Who Became A Covid MedTech Billionaire
Oct 3, 2022,07:21am EDT
Joe Kiani surmounted overwhelming personal and professional odds to build a better blood oxygen monitoring device. So why should he be afraid to push his scrappy company into consumer electronics, challenging firms 100 times its size?
J
oe Kiani had achieved the dream. Masimo Corp., which he founded and runs as CEO and chairman, had carved out a lucrative niche as one of the top makers of pulse oximeters, those fingertip sensors that hospitals use to measure oxygen saturation in patientsâ blood. Masimo had made Kiani, who immigrated in poverty to the U.S. from Iran as a child, richâa billionaire, by Forbesâ reckoning. As an electrical engineer, he took pride in the fact that devices he had personally designed were excellent, commanding a slightly bigger share of the U.S. hospital pulse oximeter market than its chief competitor, Nellcor, which is a unit of Medtronic, a company roughly 15 times Masimoâs size. Together the two companies account for about 90% of sales.
Itâs a profitable enterprise, tooâlast year Masimo, based in Irvine, California, earned $223 million on $1.2 billion in revenue. Amid a rising stock market and bolstered by increased demand for Masimoâs technology due to Covid-19 (low blood oxygen levels being an early warning that the disease is getting worse), the companyâs shares climbed 85% from early 2020 through the end of 2021, giving Masimo a market capitalization of more than $16 billion.
Then Kiani decided to complicate the dream. After the market closed this February 15, Masimo announced it was spending just over $1 billion to buy Sound United, a consumer-focused audio, speaker and headphone business that owns brands such as Marantz, Denon, Bowers & Wilkins and Boston Acoustics. The next day, Masimoâs stock plunged 37%, wiping out $5 billion in market value.
Kiani was shocked. âWe thought [investors] would say âawesome!â And given our track recÂord, weâre not going to screw it up,â he declares, perched on an ecru couch in his compulsively neat office. âYou know what one of them said to me? Very angry shareholder, big shareholder? âGive it back. Donât buy it.ââ
But Mike Polark, an analyst at Wolfe Research in Boston, wasnât surprised at the negative reaction: âIn medtech, focus pays.â At eight times Ebitda, the problem wasnât that Kiani had overpaid for Sound United. Itâs also a healthy, profitable business expected to bring Masimoâs revenue to $2 billion this year, a 67% increase. âThe issue for Wall Street is strategic direction,â Polark continues. âWhy is Masimo selling over-the-ear headphones?â
The acquisition would instantly render Kianiâs company less profitable. The gross margin on Masimoâs medical device business had been a lofty 65.8%. In commodity consumer electronics, like headphones, 20% is more typical.
The move prompted activist investor Politan Capital Management, a year-old firm led by Quentin Koffeyâa veteran of activist investor Paul Singerâs Elliott Management and hedge fund D.E. Shawâto acquire a nearly 9% stake in Masimo, according to an early August filing. PoliÂtan would not comment on its plans, but back in March the firm helped push health insurance firm Centene to replace its CEO.
https://www.forbes.com/sites/kerryadolan/2022/10/03/meet-the-iranian-immigrant-who-became-a-covid-medtech-billionaire/?sh=77ab15a82abc